Figure 3
Figure 3. Kinetics of CD38+ and CD38− CLL cells in each patient studied. Curves represent the fraction (f) of labeled cells at the 3 time points studied. Note that different levels of 2H enrichment were observed among patients, and the graphs have different scales. Vertical dotted lines indicate the end of 2H2O assumption. Based on the slopes of the CD38+ and CD38− kinetic curves, 2 groups of patients were defined, A and B. (A) In group A, CD38+ cells rapidly achieve maximal 2H enrichment levels at the end of the labeling period; 2H incorporation in these cells subsequently falls during washout. (B) Patients in group B are characterized by similar kinetic patterns of both CD38+ and CD38− fractions with delayed appearance and slow achievement of maximal levels of labeled cells.

Kinetics of CD38+ and CD38 CLL cells in each patient studied. Curves represent the fraction (f) of labeled cells at the 3 time points studied. Note that different levels of 2H enrichment were observed among patients, and the graphs have different scales. Vertical dotted lines indicate the end of 2H2O assumption. Based on the slopes of the CD38+ and CD38 kinetic curves, 2 groups of patients were defined, A and B. (A) In group A, CD38+ cells rapidly achieve maximal 2H enrichment levels at the end of the labeling period; 2H incorporation in these cells subsequently falls during washout. (B) Patients in group B are characterized by similar kinetic patterns of both CD38+ and CD38 fractions with delayed appearance and slow achievement of maximal levels of labeled cells.

Close Modal

or Create an Account

Close Modal
Close Modal